Literature DB >> 22759525

The benefit of hypothermia in experimental ischemic stroke is not affected by pethidine.

Emily S Sena1, Amy L Jeffreys, Susan F Cox, Stephen A Sastra, Leonid Churilov, Sarah Rewell, Peter E Batchelor, H Bart van der Worp, Malcolm R Macleod, David W Howells.   

Abstract

BACKGROUND: Hypothermia is a promising experimental treatment for acute ischemic stroke. Human trials are still at an early stage, with the focus now on using hypothermia in awake patients. Pethidine (meperidine) is the principle agent used to control shivering in humans; however, whether it has any modulating effects on the neuroprotective efficacy of hypothermia is unknown. AIM: The aim of this study was to determine if pethidine influences the neuroprotective effect of hypothermia in experimental stroke.
METHODS: Seventy-two male spontaneously hypertensive rats were anesthetized with isoflurane and randomly assigned to either normothermia (37. 4 °C rectal temperature); hypothermia (33 °C maintained for 130 mins); normothermia plus pethidine (2.5 mg/kg); or hypothermia plus pethidine. Temporary (90 mins) endovascular occlusion of the middle cerebral artery was induced blinded to treatment allocation and was confirmed with laser Doppler flowmetry. Pethidine and cooling were started immediately after vessel occlusion. Animals in the normothermia group had active temperature management using a heat lamp and fan. Assessments of outcome were carried out 24 after the induction of injury.
RESULTS: Thirteen animals met our prespecified criteria for exclusion, and data for 59 rats were presented here. Hypothermia was associated with a 63% reduction in infarct size, and pethidine had no significant impact on the efficacy of hypothermia. No effects were observed in neurobehavioral outcome or edema volume across experimental groups.
CONCLUSIONS: The effects of hypothermia in a model of focal ischemia are not affected by administration of pethidine.
© 2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22759525     DOI: 10.1111/j.1747-4949.2012.00834.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  3 in total

Review 1.  Non-pharmaceutical therapies for stroke: mechanisms and clinical implications.

Authors:  Fan Chen; Zhifeng Qi; Yuming Luo; Taylor Hinchliffe; Guanghong Ding; Ying Xia; Xunming Ji
Journal:  Prog Neurobiol       Date:  2014-01-07       Impact factor: 11.685

2.  Hypothermia revisited: Impact of ischaemic duration and between experiment variability.

Authors:  Sarah Sj Rewell; Amy L Jeffreys; Steven A Sastra; Susan F Cox; John A Fernandez; Elena Aleksoska; H Bart van der Worp; Leonid Churilov; Malcolm R Macleod; David W Howells
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-13       Impact factor: 6.200

Review 3.  Systematic Review and Meta-Analysis of the Efficacy of Interleukin-1 Receptor Antagonist in Animal Models of Stroke: an Update.

Authors:  Sarah K McCann; Fala Cramond; Malcolm R Macleod; Emily S Sena
Journal:  Transl Stroke Res       Date:  2016-08-15       Impact factor: 6.829

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.